Cathy Royer

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao et al. · Nature Medicine · 2011 · 692 citations · Full text

Life Sciences, Infectious Diseases, Molecular Medicine +14

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81

Mirjam B. Zeisel, George Koutsoudakis, Eva K. Schnober et al. · Hepatology · 2007 · 245 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Inhibition of hepatitis C virus infection by anti‐claudin‐1 antibodies is mediated by neutralization of E2–CD81–Claudin‐1 associations†

Sophie Krieger, Mirjam B. Zeisel, Christopher Davis et al. · Hepatology · 2009 · 172 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes

Isabel Fofana, Sophie Krieger, Fritz Grunert et al. · Gastroenterology · 2010 · 163 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting

Volker Schäfer, Hagen von Briesen, Reinhard Andreesen et al. · Pharmaceutical Research · 1992 · 142 citations

Life Sciences, Immunology, Infectious Diseases +14